Moderna (MRNA) had the worst year in 2023 by a US stock in the S&P 500 (GSPC) in 2023, returning -45%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Moderna (MRNA) | 2023 | -45.01% |
Dollar General (DG) | 2023 | -44.46% |
Estee Lauder Companies (EL) | 2023 | -42.02% |
Pfizer (PFE) | 2023 | -41% |
Paycom Soft (PAYC) | 2023 | -34.39% |
Albemarle (ALB) | 2023 | -33.5% |
Texas Pacific Land Trust (TPL) | 2023 | -31.31% |
AES (AES) | 2023 | -30.97% |
Insulet (PODD) | 2023 | -27.55% |
Hormel Foods (HRL) | 2023 | -27.41% |
Nextera Energy (NEE) | 2023 | -25.98% |
Bristol-Myers Squibb (BMY) | 2023 | -25.95% |
EnergySolutions (ES) | 2023 | -24.03% |
ConAgra Foods (CAG) | 2023 | -22.82% |
Revvity (RVTY) | 2023 | -22.8% |
Incyte (INCY) | 2023 | -21.68% |
Baxter International (BAX) | 2023 | -21.02% |
Campbell’s (CPB) | 2023 | -21.01% |
Devon Energy (DVN) | 2023 | -20.82% |
Archer-Daniels-Midland (ADM) | 2023 | -20.33% |
International Flavors & Fragrances (IFF) | 2023 | -19.92% |
APA (APA) | 2023 | -19.88% |
General Mills (GIS) | 2023 | -19.69% |
Dominion Energy (D) | 2023 | -19.13% |
Genuine Parts (GPC) | 2023 | -17.97% |
